» Articles » PMID: 7582312

Alveolar Inflammation and Its Relation to Emphysema in Smokers

Overview
Specialty Critical Care
Date 1995 Nov 1
PMID 7582312
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

The prevalent theory in the pathogenesis of emphysema proposes that increased numbers of activated neutrophils and/or alveolar macrophages produce large amounts of proteases, an activity that cannot be regulated by alpha 1-antiproteases, resulting in lung destruction. However, the cells in the lung parenchyma of smokers have not been properly identified. We characterized and quantitated the inflammatory cell load in the lungs of smokers and correlated these findings with the degree of lung destruction. Twenty-one patients, six nonsmokers and 15 smokers, undergoing lung resection were studied. Lungs or lobes were fixed and stained for light microscopy and neutrophil identification and immunohistochemically stained for identification of lymphocytes and macrophages. By point counting, we determined the extent of emphysema by the volume density of the lung parenchyma (Vvalv), and the different cell numbers per cubic millimeter in all lungs. In nonsmokers Vvalv was greater than in smokers. The number of neutrophils/mm3 of lung correlated directly with the Vvalv, (r = 0.71, p < 0.01), whereas the number of alveolar macrophages (r = -0.70) and T-lymphocytes (r = -0.78) correlated negatively with the Vvalv. The number of T-lymphocytes correlated negatively with the number of neutrophils (r = -0.58) and positively with the numbers of alveolar macrophages (r = 0.77). Our data suggest that as long as the inflammatory reaction is predominantly of neutrophils there is no destruction of the lung. However, the extent of lung destruction becomes evident, and its extent is directly related to the number of alveolar macrophages and T-lymphocytes/mm3. We conclude that the T-lymphocyte might be importantly implicated in the pathogenesis of emphysema in smokers.

Citing Articles

Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema.

Fortis S, Guo J, Nagpal P, Chaudhary M, Newell Jr J, Gerard S Am J Respir Crit Care Med. 2024; 210(12):1432-1440.

PMID: 38843116 PMC: 11716031. DOI: 10.1164/rccm.202310-1825OC.


Korean Red Ginseng suppresses emphysematous lesions induced by cigarette smoke condensate through inhibition of macrophage-driven apoptosis pathways.

Kim J, Kim J, Kim C, Jeong J, Ko J, Kim T J Ginseng Res. 2024; 48(2):181-189.

PMID: 38465217 PMC: 10920012. DOI: 10.1016/j.jgr.2023.11.001.


A bidirectional Mendelian randomization study investigating the relationship between genetically predicted systemic inflammatory regulators and chronic obstructive pulmonary disease.

Zhang M, Wang S, Guan Q, Wang J, Yan B, Zhang L Heliyon. 2024; 10(1):e24109.

PMID: 38268600 PMC: 10806290. DOI: 10.1016/j.heliyon.2024.e24109.


Mucosal immune alterations at the early onset of tissue destruction in chronic obstructive pulmonary disease.

De Fays C, Geudens V, Gyselinck I, Kerckhof P, Vermaut A, Goos T Front Immunol. 2023; 14:1275845.

PMID: 37915582 PMC: 10616299. DOI: 10.3389/fimmu.2023.1275845.


cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features.

Hasani Nourian Y, Salimian J, Ahmadi A, Salehi Z, Karimi M, Emamvirdizadeh A Biochem Biophys Rep. 2023; 34:101438.

PMID: 36865738 PMC: 9971187. DOI: 10.1016/j.bbrep.2023.101438.